Current Projects
Search
 

Home
Search for Projects
View Projects
Project Title
by Subject/Focus Area
by Board/Committee
by Major Unit
Provisional Committee Appointments Open for Formal Public Comments
by Last Update
Meeting Information
Conflict of Interest Policy
Committee Appointment Process
FAQ
  Committee Membership
More Project Information and to provide FEEDBACK on the Project

 Printer Friendly Version


Committee Membership Information




Project Title: A National Strategy for the Elimination of Hepatitis B and C

PIN: IOM-BPH-15-07        

Major Unit:
Institute of Medicine

Sub Unit: Board on Population Health and Public Health Practice

RSO:

Buckley, Gillian

Subject/Focus Area:  Health and Medicine


Committee Membership
Date Posted:   11/09/2015


Dr. Brian L. Strom - (Chair)
Rutgers, The State University of New Jersey, Newark

Brian L. Strom, M.D., M.P.H. is the Inaugural Chancellor of Rutgers Biomedical and Health Sciences (RBHS) and the Executive Vice President for Health Affairs at Rutgers University. RBHS is comprised of eight schools and five centers/institutes, and includes academic, patient care, and research facilities. These are most of the units of the former University of Medicine and Dentistry of New Jersey (UMDNJ), now dissolved, several Rutgers University units with health-related missions, and two research units historically co-managed by Rutgers and UMDNJ. The integration of these entities is designed to create a single organization that will lead to new models for clinical care and community service, educate the next generation of health care providers utilizing health care team approaches, and conduct research. Dr. Strom was formerly the Executive Vice Dean of Institutional Affairs, Founding Chair of the Department of Biostatistics and Epidemiology, Founding Director of the Center for Clinical Epidemiology and Biostatistics, and Founding Director of the Graduate Program in Epidemiology and Biostatistics, all at the Perelman School of Medicine of the University of Pennsylvania (Penn).
Dr. Strom earned a B.S. in Molecular Biophysics and Biochemistry from Yale University in 1971, and then an M.D. degree from the Johns Hopkins University School of Medicine in 1975. From 1975–1978 he was an intern and resident in Internal Medicine and from 1978–1980 he was an NIH fellow in Clinical Pharmacology at the University of California, San Francisco. He simultaneously earned an M.P.H. Degree in Epidemiology at the University of California, Berkeley. He has been on the faculty of the University of Pennsylvania School of Medicine since 1980. The Center for Clinical Epidemiology and Biostatistics (CCEB) that he created at Penn includes over 550 faculty, research and support staff, and trainees. At the time Dr. Strom stepped down, CCEB research received nearly $49 million/year in extramural support. Its total budget was approximately $67 million.
Although Dr. Strom's interests span many areas of clinical epidemiology, his major research interest is in the field of pharmacoepidemiology, i.e., the application of epidemiologic methods to the study of drug use and effects. He is recognized as a founder of this field and for his pioneer work in using large automated databases for research. He is editor of the field's major text (now in its fifth edition) and Editor-in-Chief for Pharmacoepidemiology and Drug Safety, the official journal of the International Society for Pharmacoepidemiology. As one of many specific contributions, his research was pivotal in prompting the American Heart Association and American Dental Association to reverse 50 years of guidelines, and recommend against use of antibiotics to prevent infective endocarditis, instead of recommending for this widespread practice. In addition to writing more than 600 papers, and 11 books, he has been principal investigator for more than 275 grants, including over $115 million in direct costs alone. Dr. Strom has been invited to give more than 400 talks outside his local area, including presentations as the keynote speaker for numerous international meetings. He has been a consultant to NIH, FDA, CDC, USP, AAMC, JCAHO, foreign governments, most major pharmaceutical manufacturers, and many law firms.
Dr. Strom is also a nationally recognized leader in clinical research training. At the Perelman School of Medicine, Dr. Strom developed graduate training programs in epidemiology and biostatistics. More than 625 clinicians have been trained or are in training through the largest of these training programs, which leads to a Master of Science in Clinical Epidemiology degree. All but approximately 65 former trainees in this program have appointments in academic or other research institutions. Dr. Strom was PI or Co-PI of 11 different NIH-funded training grants (T32, D43, K12, and K30), each of which supported clinical epidemiology trainees in different specialties and subspecialties, and has been the primary mentor for more than 40 former and current clinical research trainees and numerous junior faculty members. Internationally, Dr. Strom was a key contributor to the conceptualization and planning that led to the development of the International Clinical Epidemiology Network (INCLEN), created in 1979 with support provided by the Rockefeller Foundation to provide clinical research training to clinicians from selected developing country sites. Penn was an INCLEN founding member and one of five training centers. INCLEN Phase I, from 1979 through 1995, resulted in the establishment of 26 clinical epidemiology units in Latin America, India, Africa, and Southeast Asia. The Penn training program alone, led by Dr. Strom, trained 63 INCLEN trainees.
Dr. Strom was a member of the Board of Regents of the American College of Physicians, the Board of Directors of the American Society for Clinical Pharmacology and Therapeutics, and the Board of Directors for the American College of Epidemiology, and is currently a member of the Board of Directors for the Association for Patient-Oriented Research. He was previously President of the International Society for Pharmacoepidemiology and the Association for Clinical Research Training. Dr. Strom was on the Drug Utilization Review Committee and the Gerontology Committee of the United States Pharmacopoeia, served on the Drug Safety and Risk Management Advisory Committee for the US Food and Drug Administration, chaired the Institute of Medicine (IOM) Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, chaired the IOM Committee on Smallpox Vaccine Program Implementation, chaired the IOM Committee to Review NIOSH’s Traumatic Injury Program, chaired the IOM Committee on the Consequences of Reducing Sodium in the Population, was a member of the IOM Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, and was a member of the IOM Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. He is currently a member of the IOM Drug Forum.
Dr. Strom is a member of the American Epidemiology Society, and is one of a handful of clinical epidemiologists ever elected to the American Society of Clinical Investigation and American Association of Physicians. He has also been an elected member of the IOM of the National Academy of Sciences since 2001. Dr. Strom received the 2003 Rawls-Palmer Progress in Medicine Award from the American Society for Clinical Pharmacology & Therapeutics, the Naomi M. Kanof Clinical Investigator Award of the Society for Investigative Dermatology, the George S. Pepper Professorship of Public Health and Preventive Medicine, and in 2006 he received the Sustained Scientific Excellence Award from the International Society for Pharmacoepidemiology. In addition, Dr. Strom was named the 2008 recipient of the John Phillips Memorial Award for Outstanding Work in Clinical Medicine. This award is from the American College of Physicians (ACP) and is considered to be one of the highest awards in Internal Medicine. Dr. Strom also received the 2013 Association for Clinical and Translational Science/American Federation for Medical Research National Award for Career Achievement and Contribution to Clinical and Translational Science for translation from clinical use into public benefit and policy. Penn awards that Dr. Strom received include the Class of 1992 Class Teaching Award and the Samuel Martin Health Evaluation Sciences Research Award. Dr. Strom received the 2004 Christian R. and Mary F. Lindback Award, the University’s most prestigious teaching award, in recognition of the contribution he has made in his career to clinical research teaching.

Dr. Jon Andrus
Sabin Vaccine Institute

Jon Andrus, M.D., joined the Sabin Vaccine Institute in October 2014 where he serves as Executive Vice President and Director of the Vaccine Advocacy and Education (VAE) program. VAE works to reduce the suffering caused by vaccine preventable diseases by bringing together key stakeholders to foster collaboration, share best practices, and develop improved vaccine policy and access. Previously, Dr. Andrus served as Deputy Director of the Pan American Health Organization (PAHO). Prior to that, he was the Lead Technical Advisor for PAHO’s immunization program, providing oversight and guidance for technical cooperation to member countries.
Dr. Andrus holds faculty appointments at the University of California, San Francisco, and the Johns Hopkins University Bloomberg School of Public Health. He began his global health career as a Peace Corps volunteer, serving as a District Medical Officer in Malawi and has since held positions in the U.S. Centers for Disease Control’s (CDC) Global Immunization Division, as Head, Vaccinology and Immunization Program at the Institute for Global Health at the Universities of California at San Francisco and Berkeley, and as Director of the Global Health MPH Program at GWU.
Dr. Andrus has received numerous other awards for his leadership in the eradication of polio, measles, rubella, and congenital rubella syndrome, as well as the introduction of new vaccines in developing countries. In 2013, Dr. Andrus received the Transformational Leadership Award of the University California. In 2011, he received the Global Leadership Award of the Pneumococcal Awareness Committee of Experts. In 2007, he received the Philip R. Horne award for global leadership in immunization. In 2000, he received the Distinguished Service Medal, the highest award of the United States Public Health Service, for his leadership in working to eradicate polio in Southeast Asia. Dr. Andrus holds a Bachelor of Science degree from Stanford University, obtained his medical degree from the University of California, Davis, and completed his residencies in family medicine at the University of California, San Francisco School of Medicine, and preventive medicine at the CDC. He has published more than 100 scientific peer-reviewed papers on disease eradication, the introduction of new vaccines, and primary care.

Dr. Andrew Aronsohn
The University of Chicago Hospitals

Andrew Aronsohn, M.D., is an assistant professor of medicine in the Center for Liver Diseases at the University of Chicago Medical Center. Dr. Aronsohn is also a faculty member at the MacLean Center for Clinical Medical Ethics at the University of Chicago. Dr. Aronsohn is also a faculty member at the MacLean Center for Clinical Medical Ethics at the University of Chicago. Dr. Aronsohn is the co-principal investigator of HepCCATT, an initiative to diagnose, link to care and treat HCV in the Chicago area. This project utilizes telehealth technology to expand HCV management into the primary care setting. Dr. Aronsohn is a member of the AASLD / IDSA HCV guidance writing committee and has a busy clinical practice which includes both general and transplant hepatology.

Mr. Daniel R. Church
Massachusetts Department of Health

Daniel R. Church, M.P.H. is the viral hepatitis prevention coordinator and an epidemiologist in the Division of Epidemiology and Immunization at the Massachusetts Department of Public Health. In this role he has helped to develop and implement the statewide viral hepatitis program including disease surveillance, medical management services, counseling and testing programs, adult vaccination programs, educational campaigns for providers, patients and communities, and evaluation of projects. He was a member of the Institute of Medicine committee that authored the report Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Mr. Church received his M.P.H. in epidemiology and biostatistics from the Boston University School of Public Health.

Dr. Seymour S. Cohen
Marine Biological Laboratory

Seymour S. Cohen, Ph.D. has worked on bacterial viruses since 1945, offering the first systematic exploration of the biochemistry of virus-infected cells and of how viruses multiply. His subsequent research included delineating the phenomenon of thymineless death, developing derivatives of ara-A compound, working on RNA synthesis, studying the effects of polyamines on metabolic systems, and studying plant viruses (including viral cations). Much of his research has contributed to the chemical treatment of cancer and viral infections.

Dr. Alison A. Evans
Drexel University School of Public Health

Alison A. Evans, Sc.D. is an associate professor in the Department of Epidemiology and Biostatistics at Drexel University Dornsife School of Public Health. She is also adjunct research faculty in the Public Health Program of the Hepatitis B Foundation, Doylestown, PA. Prior to joining Drexel, she was an associate member at the Fox Chase Cancer Center. Her research interests include the epidemiology and natural history of the hepatitis B virus and other chronic viral infections, the association of chronic viral infections with cancer, and public health interventions to decrease the burden of HBV infection globally. She received her ScD in epidemiology from the Harvard School of Public Health.

Mr. Paul Kuehnert
Robert Wood Johnson Foundation

Paul Kuehnert, D.N.P., R.N., F.A.A.N., is a nurse and public health expert who currently oversees RWJF's work in building bridges among the health care system, public health, and other community services and agencies to improve overall population health. As a former county health officer in Illinois and former deputy state health officer in Maine, he brings extensive public health experience to the group. He has an acute awareness of the strengths of local and state public health agencies in combatting conditions such as hepatitis B and C as well as the challenges they face. He is extremely familiar with the topics of surveillance, implementation of disease control programs, screening, epidemiology, and community based program implementation (see in particular his prior work in HIV/AIDS).

Dr. Vincent Lo Re
University of Pennsylvania

Vincent Lo Re III, M.D., M.S.C.E., earned his medical degree from the University of Pennsylvania, completed an internship and residency in internal medicine and completed a fellowship in infectious diseases at the Hospital of the University of Pennsylvania. He also earned a Master of Science in clinical epidemiology degree from the University of Pennsylvania. Dr. Lo Re has a nationally recognized clinical research program in viral hepatitis epidemiology. He joined the Penn faculty in 2008 and is currently an assistant professor of medicine in the Division of Infectious Diseases and assistant professor of epidemiology in the Department of Biostatistics and Epidemiology at Penn. He is also co-director of the HIV/Viral Hepatitis Scientific Working Group within the Penn Center for AIDS Research and a senior scholar in the Penn Center for Clinical Epidemiology and Biostatistics. Additionally, he is co-chair of the Liver Core of the Veterans Aging Cohort Study. He has been invited to speak on topics related to chronic viral hepatitis infection, HIV/viral hepatitis coinfection, and pharmacoepidemiology at ID Week, the Interscience Conference on Antimicrobial Agents and Chemotherapy, Conference on Retroviruses and Opportunistic Infections, FDA, and the International Society for Pharmacoepidemiology. He has been a standing member of the FDA’s Antiviral Drug (now Anti-Infective) Advisory Committee since 2014. He also served as a member of the National Institute of Allergy and Infectious Diseases study section reviewing the Centers of Excellence for Influenza Research and Surveillance.

Dr. Kathleen Maurer
Connecticut Department of Correction

Kathleen Maurer, M.D., M.P.H., M.B.A., is the Connecticut Department of Correction’s director of health and addiction services and medical director. Before assuming her current post in 2011, she was assistant medical director at Correctional Managed Health Care, a division of the University of Connecticut Health Center, which contracts with the state corrections department for offender medical care. During her career, Dr. Maurer has provided hands-on clinical care and medical program management in the private sector. In the realm of correctional care, she is particularly interested in the quality of patient care, in the role of correctional healthcare in the broader scope of public health such as in the treatment of hepatitis C virus in our offender-patients, and in facilitating re-entry programs through integration of community and correctional healthcare. Several of her recent and ongoing initiatives include working to expand Medicaid access to halfway house residents and to integrate Medicaid utilization management with the correctional system. She is also developing a system-wide medication assisted therapy program for the Connecticut DOC. Dr. Maurer is the primary author of the monograph entitled “Hepatitis C in Correctional Settings: Challenges and Opportunities,” and published by the American Correctional Association. Dr. Maurer earned her MD from Yale University School of Medicine. She also earned an MPH from Yale. She holds an MBA from the University of Connecticut and is board-certified in internal medicine, occupational and environmental medicine, and addiction medicine.

Mr. Randall R. Mayer
Iowa Department of Public Health

Randall R. Mayer, M.S., M.P.H. serves as interim director of the Division of Behavioral Health at the Iowa Department of Public Health. While working with the Iowa Department of Public Health, Mr. Mayer served as the chief of the Bureau of HIV, STD, and Hepatitis, HIV surveillance coordinator and the HIV and Hepatitis program manager. He received his MPH in epidemiology from the University of Minnesota and his MS in plant cell physiology from Purdue University.

Dr. Shruti Mehta
Johns Hopkins University

Dr. Shruti Mehta, Ph.D., M.P.H., is a professor in the Johns Hopkins Bloomberg School of Public Health. Her primary research interests include working with hard-to reach populations to understand the epidemiology, natural and treated history of HIV, hepatitis C virus (HCV) and HIV/HCV co-infection; Populations of interest include injection drug users and men who have sex with men as well as their sexual partners in both Baltimore and international settings, particularly India; Special interest in identifying and overcoming barriers to care and treatment of HIV and hepatitis C virus among such populations.

Dr. Stuart C. Ray
Johns Hopkins Bloomberg School of Public Health

Stuart C. Ray, M.D. serves as vice chair of medicine for Data Integrity and Analytics, associate fellowship program director and professor in the Division of Infectious Diseases within the Department of Medicine, with secondary appointments in Viral Oncology and Health Sciences Informatics, at the Johns Hopkins University School of Medicine. He directs the virology laboratory and is a clinical investigator in the Center for Viral Hepatitis Research in the Division of Infectious Diseases. He is a faculty member of the graduate immunology program, the graduate pharmacology program, and of the Janeway Firm of the Osler Medical Service. Dr. Ray received his M.D. from Vanderbilt University School of Medicine in 1990. After an internship and residency at Johns Hopkins Hospital, he continued there as an assistant chief of service and fellow in infectious diseases. During his fellowship, he studied the immunology and sequence variation of HIV in the laboratory of Dr. Robert Bollinger. During that time, he developed an interest in HIV sequence variation during antiretroviral therapy in a productive collaboration with Dr. Robert Siliciano that continues to the present.
In 1997, Dr. Ray joined the Johns Hopkins faculty, and under the mentorship of Dr. David Thomas shifted his primary research focus to hepatitis C virus (HCV). His laboratory work has focused on the sequence variation of HCV during acute and chronic infection, developing and applying computational and molecular biology tools to underlying mechanisms including stochastic variation, immune selection, and viral fitness. He continues to care for inpatients and outpatients with HIV, HCV, and other infectious diseases.


Dr. Arthur L. Reingold
University of California, Berkeley

Arthur Reingold, M.D., is Edward Penhoet Distinguished Professor of Global Health and Infectious Diseases at the School of Public Health, University of California, Berkeley (UCB). He is also professor of epidemiology and biostatistics and clinical professor of medicine at the University of California, San Francisco (UCSF). His research interests include emerging and reemerging infections and vaccine-preventable diseases in the United States and developing countries. Reingold serves on the World Health Organization's Strategic Advisory Group of Experts on vaccines and vaccine policy as vice-chair. He is also director of the California Emerging Infections Program, and of the U.S. National Institutes of Health Fogarty AIDS International Training and Research Program at the UCB/UCSF. His recent publications include articles on the impact of the introduction of pneumococcal conjugate vaccine in the United States and related topics. Before joining the faculty at UCB, Reingold worked for eight years at the Centers for Disease Control and Prevention. He is a member of the National Academy of Medicine.

Dr. Samuel So
Stanford University School of Medicine

Samuel So, M.B. is a professor of surgery and the Lui Hac Minh Professor at Stanford University. He is also the director of the Asian Liver Center and director of the Multidisciplinary Liver Cancer Program at the same institution. He has published numerous studies on solid organ transplantation, gastric and liver cancers. Dr. So is well known for his work on hepatitis B and liver cancer education and prevention programs. Through his research, Dr. So has identified the need for a public health approach to liver cancer prevention among recent Asian immigrants and first and second generation Asians living in the US. These populations have not been the typical focus of US screening and prevention programs. Dr. So is listed among the Best Doctors in America published by Woodward/White Inc. For his work in education and prevention, he received the 2005 National Leadership Award from the New York University Center for the Study of Asian American Health, and the 2008 American Liver Foundation Salute to Excellence Award. He is a member of the IOM's Board on Population Health and Public Health Practice. Dr. So received his MB, BS in medicine and surgery from the University of Hong Kong, and did postdoctoral and clinical fellowships at the University of Minnesota.

Dr. Neeraj Sood
USC Schaeffer

Neeraj Sood, Ph.D., is and Associate Professor and Vice Dean for Research at the USC Schaeffer Center and Sol Price School of Public Policy. In addition, he currently serves as the Director of Research at the Leonard D. Schaeffer Center for Health Policy and Economics and is an Associate Professor at the Price School and the School of Pharmacy’s Department of Pharmaceutical and Health Economics. His prior work has focused on the economics of innovation, HIV/AIDS, health care financing, and global health.
His research has been published in several peer-reviewed journals and books including leading journals in economics, medicine and health policy. He has testified frequently on health policy issues before state legislators and his work has also been featured in several media outlets including the New York Times, Washington Post, U.S. News and World Report, and Scientific American. Dr. Sood was the finalist for the 16th and 21st Annual NIHCM Health Care Research Award, recognizing outstanding research in health policy. He was also the 2009 recipient of the Eugene Garfield Economic Impact Prize, recognizing outstanding research demonstrating how medical research impacts the economy.
Dr. Sood is on the editorial boards of Health Services Research and Forum for Health Economics and Policy and is a research associate at the National Bureau of Economic Research (NBER). Prior to joining USC, Dr. Sood was a senior economist at RAND and Professor at the Pardee RAND Graduate School.

Dr. Grace Wang
International Community Health Services

Grace Wang, M.D., is a board certified family physician for International Community Health Services in Seattle, Washington. Dr. Wang graduated from the University of Michigan with a degree in Early Childhood Education. She received her medical training at Cornell University Medical College in New York City and has a Master’s in Public Health also from the University of Michigan. Dr. Wang has worked in primary care and public health in New York City and Seattle. She is currently a member of the Executive Committee for the National Association of Community Health Centers (NACHC) Board of Directors and also serves on the boards for Project Access Northwest and Kin On.

Dr. Lucy E. Wilson
Department of Health and Mental Hygiene

Lucy Wilson, M.D., Sc.M., is a Medical Epidemiologist and infectious disease physician at the Maryland Department of Health and Mental Hygiene, where she serves as the Chief of the Center for Surveillance, Infection Prevention and Outbreak Response. At the State of Maryland, Dr. Wilson implements surveillance and prevention of reportable infectious diseases (including hepatitis B and C infections), consults on infection control issues across the healthcare continuum and in the general community, and oversees Maryland’s outbreak responses, including food-related outbreaks, novel influenza pandemic response, and Ebola Virus Disease response. Dr. Wilson is the Principal Investigator of the Healthcare Associated Infections (HAI) branch of the CDC/Maryland Emerging Infections Program, conducting HAI surveillance and prevention research and is the medical advisor for the CDC grant “Community-based Programs to Test and Cure Hepatitis C” in Maryland. Dr. Wilson is an adjunct assistant professor at the Johns Hopkins University School of Medicine, where she previously was on the Johns Hopkins School of Medicine Division of Infectious Diseases faculty as the Medical Director of the Johns Hopkins HIV County Program, and where her research focused on the natural history of hepatitis C in injection drug users and HIV clinical outcomes research.

Dr. Gillian Buckley - (Staff Officer)
Institute of Medicine


Committee Membership Roster Comments
Note 12/11/2015: There were additional appointments to the committee following the initial posting of the membership on 11/9/2015: Dr. Seymour Cohen was appointed on 11/15/2015, and Dr. Andrew Aronsohn and was appointed on 12/11/2015.

Statement of Committee Composition
The committee will comprise expertise in viral hepatitis, disease elimination, public health surveillance and infrastructure, substance abuse prevention and treatment, clinical medicine, and health care costs.